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In addition to a characteristic set of essential genes coronaviruses contain several so-called group-specific genes. These
genes differ distinctly among the three coronavirus groups and are specific for each group. While the essential genes encode
replication and structural functions, hardly anything is known about the products and functions of the group-specific genes.
As a first step to elucidate their significance, we deleted the group-specific genes from the group 2 mouse hepatitis virus
(MHV) genome via a novel targeted recombination system based on host switching (L. Kuo, G. J.Godeke, M. J. Raamsman,
P. S. Masters, and P. J. M. Rottier, 2000, J. Virol. 74, 1393–1406). Thus, we obtained recombinant viruses from which the two
clusters of group-specific genes were deleted either separately or in combination in a controlled genetic background. As all
recombinant deletion mutant viruses appeared to be viable, we conclude that the MHV group-specific genes are nonessen-
tial, accessory genes. Importantly, all deletion mutant viruses were attenuated when inoculated into their natural host, the
mouse. Therefore, deletion of the coronavirus group-specific genes seems to provide an attractive approach to generateINTRODUCTION
Among the variety of proteins encoded by viruses,
those that are responsible for viral replication and virion
structure are of primary importance. In addition to these
fundamental elements, however, many viruses specify a
diverse collection of proteins, the functions of which are
often still unclear, but which are known or assumed to be
beneficial to the virus. These proteins may either be
essential—operationally defined as being required for
virus replication in cell culture—or dispensable. Exam-
ples include the cytomegalovirus proteins involved in
viral immune evasion through the inhibition of MHC
class I mediated antigen presentation and the human
immunodeficiency virus Vpu and Nef proteins, which
downregulate CD4 surface expression (Emerman and
Malim, 1998; Ploegh, 1998; and references therein).
Coronaviruses constitute a family of large, positive-
sense RNA viruses that usually cause respiratory or
intestinal infections in a number of different species,
generally in a species-specific fashion. Based on anti-
genic and genetic criteria, they have been divided into
three distinct groups. The feature that all coronaviruses
1 To whom correspondence and reprint requests should be ad-
dressed at Virology Division, Department of Infectious Diseases andhave in common is a characteristic set of essential
genes encoding replication and structural functions. In-
terspersed among these genes are clusters of group-
specific open reading frames (ORFs) that are homolo-
gous within each group but that differ profoundly among
the groups (Lai and Cavanagh, 1997).
Of the common essential genes, the predominant one
(ORF 1ab) occupies about two-thirds of the genome.
Located at the 5 end of the genome, this replicase gene
encodes two large precursors, the many functional
cleavage products of which are collectively responsible
for RNA replication and transcription. The other common
essential genes specify the four basic structural proteins
N, M, E, and S. The nucleocapsid (N) protein packages
the viral RNA, forming the core of the virion. This nucleo-
capsid core structure is surrounded by a lipid envelope
in which the membrane (M) protein occurs most abun-
dantly. Associated with the M protein are the small en-
velope (E) protein and the spike (S) protein, the latter
forming the viral peplomers that are involved in virus–cell
and cell–cell fusion. The genes for these structural pro-
teins invariably occur in the order 5-S-E-M-N-3 and are
located in the 3 third of the viral genome (Lai and
Cavanagh, 1997).
In contrast, the identities and the locations of the
group-specific genes vary, and their functions have notattenuated live coronavirus vaccines. © 2002 Elsevier Science
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ruses of group 1, with feline infectious peritonitis virus
(FIPV) as probably the most complex member, have as
many as three group-specific genes located between the
S and E genes and as many as two additional ORFs
downstream of the N gene, preceding the 3-untrans-
lated region of the genome. Group 2 viruses, to which
mouse hepatitis virus (MHV) belongs, have two group-
specific genes, gene 2a and a hemagglutinin-esterase
(HE) ORF between ORF 1b and the S gene. Two addi-
tional group 2-specific genes, genes 4 and 5a, reside
between the S and E genes. Finally, the group 3 viruses,
represented by the prototype infectious bronchitis virus
(IBV), have two group-specific genes between the S and
E genes as well as two between the M and N genes.
For some strains of MHV, the expression of one or
more of the group-specific genes has been demon-
strated (Ebner et al., 1988; Yokomori et al., 1991; Zoltick et
al., 1990). Indeed, for the best characterized group 2
specific gene product, the HE protein, hemagglutinating
and acetyl-esterase enzymatic activities have been dem-
onstrated (Brian et al., 1995). However, in a number of
strains or mutants of MHV particular group-specific
genes cannot be expressed, either because of failure to
transcribe the corresponding mRNA (Luytjes et al., 1988;
Yokomori and Lai, 1991) or owing to frameshifting (Weiss
et al., 1993) or partial (Schwarz et al., 1990) or complete
deletion (Yokomori and Lai, 1991) of an ORF. Thus, many
of these genes would appear to be nonessential, at least
under certain circumstances. However, this question has
never been systematically addressed. To study the func-
tions of the group-specific genes, mutational analyses,
including their complete deletion, in a controlled genetic
background would be required. The necessary tools to
accomplish this have been devised only relatively re-
cently. While for some time a method based on targeted
RNA recombination, developed for MHV, was the only
such system described (Masters, 1999), other reverse
genetic procedures for coronaviruses are now becoming
available as well. These procedures use full-length in-
fectious cDNA clones assembled into bacterial vectors
(Almazan et al., 2000) or poxviral genomes (Thiel et al.,
2001) or assembled in vitro (Yount et al., 2000).
As a first step toward elucidating the functions of the
coronaviral group-specific genes, we have carried out a
deletion analysis of the group 2 virus MHV, strain A59. To
this end we established a novel targeted RNA recombi-
nation system, which uses switching of host cell tropism
as a selection principle for the construction of recombi-
nant viruses. The key tool in this procedure is a recently
constructed mutant virus, fMHV, in which the gene seg-
ment encoding the spike ectodomain was replaced by
that of the FIPV S gene (Kuo et al., 2000). This virus,
which grows in feline cells, but not in murine cells, was
used as the recombination partner with synthetic RNAs
in which the MHV S gene was restored and in which
additional intended mutations were engineered. Recom-
binant viruses were subsequently selected simply on the
basis of reacquisition of the ability to grow in murine
cells. Our results demonstrated the efficacy of this se-
lection system and showed that the group 2 specific
genes, 2a, HE, 4, and 5a, are not essential for viability but
that their deletion led to a significant attenuation of MHV
in its natural host, the mouse.
RESULTS
Construction of MHV deletion mutants
To examine the role of the group-specific genes of
MHV, viruses were prepared from which these genes
were deleted by using targeted RNA recombination
(Masters, 1999; Masters et al., 1994). The following viral
deletion mutants were prepared: MHV-45a, which lacks
the ORFs between the S and the E gene; MHV-2aHE,
from which the ORFs located between the 1b and the S
genes were deleted; and MHV-min, in which both these
deletions were combined (Fig. 1). As a control an iso-
genic wild-type recombinant MHV-A59 (MHV-WT) was
reconstructed by the same method used to create the
mutants. All viruses were generated by using transcrip-
tion vector pMH54 (or derivatives thereof) from which
defective RNAs were synthesized and composed of the
genomic 5 467 nucleotides fused to the 3 end (approx-
imately 8.6 kb) of the genome (Kuo et al., 2000) (Fig. 1).
For the removal of ORFs 4a, 4b, and most of 5a, a new
junction was generated between the S gene and the E
gene (Fig. 1). A small part of the 3 end of ORF5a,
corresponding to a sequence that was preserved in a
natural deletion mutant strain of MHV (MHV-S) was main-
tained (Yokomori and Lai, 1991). This sequence contains
the oligopyrimidine tract suggested to be important for
initiation of E gene translation (Jendrach et al., 1999). For
the deletion of ORFs 2a and HE the transcription vector
was extended with the 3-terminal 1200 bp of the 1b
gene, and the 1b sequence was fused to the transcrip-
tion regulatory sequence [TRS; located at the 5 end of
each gene representing a signal for the synthesis of
subgenomic (sg) mRNA (Lai and Cavanagh, 1997;
Sawicki and Sawicki, 1998)] that precedes the S gene
(Fig. 1). After generation of the transcription vectors, the
deletions were recombined into the MHV genome by
RNA–RNA recombination with the interspecies chimeric
virus fMHV (Fig. 1, top). In this virus the S glycoprotein
ectodomain is replaced by that of FIPV, providing this
virus with the ability to infect feline cells. By using fMHV
as the recipient virus for recombination with donor RNAs
carrying the murine S gene, recombinant viruses were
easily selected on the basis of their regained natural
murine cell tropism (Hsue et al., 2000; Kuo et al., 2000).
Confirmation of the recombinant genotypes
Each recombination experiment yielded viruses that
could be propagated on murine cells. The genotypes of
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the recombinant viruses were confirmed by reverse tran-
scriptase (RT)-PCR performed on genomic RNA, as
shown in Fig. 2. To verify the deletion of the ORFs 4 and
5a, the RT step was performed with primer 1092, which is
complementary to the 5 end of the M gene, while the
PCR was performed with primers 1261 and 990, which
are complementary to the 3 ends of the E and S genes,
respectively. In the case of the MHV-WT recombinant, an
RT-PCR product, corresponding in size with the predicted
1328 bp, was observed. As expected, a PCR product of
the same length was observed for MHV-2aHE. In con-
trast, both for MHV-45a and for MHV-min much smaller
RT-PCR products were detected, the decrease in size
corresponding with the deletion of 736 bp. The deletion
of ORFs 2a and HE was analyzed in a similar way. The RT
step was performed with primer 1127, which is comple-
mentary to the 5 end of the S gene. The PCR was
performed with primers 1173 and 1260, which are com-
plementary to the 3 end of the 1b gene and the 5 end
of the S gene, respectively. Both for MHV-WT and for
MHV-45a the expected PCR products (2409 bp) were
detected, which were much bigger than the PCR prod-
ucts detected for MHV-2aHE and MHV-min. The differ-
ence in size corresponded with the deletion of 2158 bp.
FIG. 1. Plasmid constructs, targeted recombination, and recombinant viruses. (A) The transcription vectors from which the defective RNAs were
produced in vitro by using T7 RNA replicase are indicated on the left side. Vector pMH54 has been described before (Kuo et al., 2000). The other
vectors were derived from pMH54 as described under Materials and Methods. The arrow at the left end of each vector indicates the T7 promoter;
the solid circle represents the polylinker between the 5-end segment of the MHV genome (denoted 5/1) and either the HE gene or the 3 end of
the replicase gene (1b), followed by the structural and group-specific genes and the 3-untranslated region and the polyadenylated segment (denoted
together as 3/A). Group 2 specific genes are represented by gray boxes. Positions of the sequences shown in (B) are indicated by arrowheads. On
top, a scheme for targeted recombination using the interspecies chimeric virus fMHV, which only grows in feline cells, is shown. The gene encoding
the hybrid S protein containing the ectodomain of the feline coronavirus S protein is indicated by a striped box in the fMHV genome. Recombinant
viruses generated by the indicated cross-over event can be selected on the basis of their ability to grow in murine cells. The genomes of these viruses
are represented on the right side. The 5- and 3-untranslated regions are denoted 5UTR and 3UTR, respectively. (B) Sequences in the transcription
vectors indicated by the arrowheads in (A) are shown and defined as follows: 1, between the S and the 4a gene; 2, between the S and the E gene;
and 3, between the 1b and the S gene. The amino acids encoded by the 3 ends of the S and 1b genes as well as the initiating methionine encoded
by the E and S genes are indicated. The MHV TRS is boxed. The Sse8387I restriction site downstream of the S gene, created by three nucleotide
mutations (bold), is underlined.
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Thus, a total of 2894 nucleotides were deleted in MHV-
min. Finally, the newly generated junctions, present in
the genomes of the deletion mutant viruses (Fig. 1B),
were confirmed by sequencing of the RT-PCR products
(data not shown). For each virus, pairs of independently
generated recombinants were plaque purified and ana-
lyzed by RT-PCR. In all cases identical results were
obtained. Since the pairs of recombinant viruses grew to
very similar titers and the different deletion mutant vi-
ruses also serve as independent controls for each other,
subsequent experiments were performed with only one
independently generated recombinant for each deletion.
RNA synthesis by MHV deletion mutants
To examine the patterns of viral RNA synthesis by the
deletion mutants, infected cells were metabolically la-
beled with [33P]orthophosphate in the presence of acti-
nomycin D. Purified total cellular RNA was analyzed by
electrophoretic separation (Fig. 3), and radioactivity in
bands of individual viral RNA species was quantitated by
phosphorimager scanning (Table 1). For the recon-
structed wild-type virus (MHV-WT), the relative molar
amounts of the six sg mRNA species and the genomic (g)
RNA were similar to those observed previously for MHV
(Hsue and Masters, 1999; Jacobs et al., 1981; Leibowitz et
al., 1981; Masters et al., 1994) with one notable excep-
tion. The 4-5a/E-M-N sgRNA, which is conventionally
denoted RNA4, was much more abundant than previ-
ously observed for this species in wild-type MHV (Hsue
and Masters, 1999; Jacobs et al., 1981; Leibowitz et al.,
1981; Masters et al., 1994). The increased synthesis of
this particular sgRNA is known to result from three nu-
cleotide changes 13, 15, and 18 bases upstream of the
consensus transcription regulatory signal, 5AAUC-
UAAAC3, that precedes gene 4 (Fig. 1B) (X. Shen, L. Kuo,
and P. S. Masters, unpublished results; Ontiveros et al.,
2001). The three base changes were made in the tran-
scription vector pMH54 to create an Sse8387I DNA re-
striction site downstream of the S gene (Kuo et al., 2000).
The reason for the transcriptional upregulation caused
by these substitutions is currently unclear.
For the deletion mutants, all variant sgRNAs had mo-
bilities that corresponded to their predicted sizes (Fig. 3
and Table 1), and no prominent extra species were ob-
served. The results of two experiments consistently in-
dicated that the relative molar amounts of the mutant
sgRNA species were quite similar to those of their wild-
type counterparts, except for a few differences (Fig. 3
FIG. 2. PCR analysis of MHV recombinants. RT-PCR was used to amplify regions of purified genomic RNA. PCR products were analyzed by
electrophoresis in 1% agarose gels stained with ethidium bromide. Sizes of relevant DNA fragments of the marker ( DNA restricted with PstI) are
indicated on the right of each gel. Primers used in each experiment, their approximate loci in the MHV genome, and the predicted sizes of the PCR
products are indicated on the right. Primers 1092 and 1127 were used in the RT step, while primer pairs 1261–990 and 1260–1173 were used for the
PCR.
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FIG. 3. Analysis of recombinant MHV-induced intracellular RNA synthesis. Mouse 17Cl1 cells were mock-infected or infected with recombinant (WT,
45a, 2aHE, or min) viruses at a multiplicity of 5 PFU per cell and were labeled with 111 Ci [33P]orthophosphate per ml from 6 to 8 h postinfection
in the presence of 20 g actinomycin D per ml, as described previously (Masters et al., 1994; Hsue and Masters, 1999). Purified total cytoplasmic
RNA was separated by electrophoresis through 1% agarose containing formaldehyde, and labeled RNA was visualized by fluorography. The genomic
composition of each virus is indicated schematically at the top. Open arrowheads and closed arrowheads, respectively, indicate wild-type and
deletion mutant genomic and subgenomic RNA species.
and Table 1). First, deletion of the ORF 4/5 cluster re-
duced the relative molar levels of M-N and E-M-N
sgRNAs as compared to their wild-type counterparts.
Second, for cells infected with the 2aHE mutant, the
S-4-5a/E-M-N, 4-5a/E-M-N, 5a/E-M-N, and M-N sgRNAs,
but not the N sgRNA, were all relatively overproduced
with respect to their recombinant wild-type counterparts.
The reasons for these changes are presently unknown,
but they may be caused by longer range effects of overall
genomic structure on the efficiency of discontinuous
transcription at individual TRSs.
Analysis of viral proteins
To analyze the viruses at the protein synthesis level,
cells were infected with the different recombinant vi-
ruses and labeled for 3 h with 35S-labeled amino acids.
The culture media were then collected and cleared by
low-speed centrifugation, while the cells were lysed.
Subsequently, culture media and cell lysates were pro-
cessed for immunoprecipitation with several antibodies
followed by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) using a 15 or 20% gel. As
shown in Fig. 4A (left), S, N, and M proteins could be
precipitated from the cell lysates with the polyclonal
anti-MHV serum. For the M protein the O-glycosylated
M3 species containing N-acetyl-galactosamine, galac-
tose, and sialic acid (Krijnse Locker et al., 1992) was
predominant. The radioactivity in each protein was quan-
titated by phosphorimager scanning of the dried gel to
determine the relative amounts of the proteins present in
the cells. From the results of three independent experi-
ments, it appeared that the M/N ratio in cells infected
with MHV-45a or MHV-min, but not with MHV-2aHE,
was significantly reduced as compared to MHV-WT in-
fected cells (Fig. 4B). Significant changes in the S/N ratio
were not observed. These results correlate with the
relative reduction of M-N sgRNA in MHV-45a and MHV-
min infected cells (Table 1).
Because the N protein has been found to be secreted
into the culture medium of infected cells also in a non-
lipid associated form (Opstelten, 1995), the extracellular
quantity of this protein is not a reliable measure of virus
assembly. We therefore used the M protein for this pur-
pose and determined the relative amount of radiolabeled
protein that is secreted. As Fig. 4A (right) shows, consis-
tently less M protein was immunoprecipitated from the
culture media of MHV-45a- and MHV-min-infected cells
than of MHV-WT- or MHV-2aHE-infected cells. Quanti-
tation of the results of three independent experiments
showed that the relative amounts of the M protein re-
leased from MHV-45a- and MHV-min-infected cells—
expressed as the ratio of extracellular over cell-bound M
protein (M outside/inside)—were decreased by approx-
imately 50% (Fig. 4B), which indicates that less viral
particles were produced.
To confirm the deletion of the 2a gene in two of our
mutant viruses, we analyzed the cell lysates by immuno-
precipitation with a protein 2a specific antiserum (Zoltick
et al., 1990) (Fig. 4C). This antiserum is known to non-
specifically immunoprecipitate the N protein which thus
served as an internal control. As expected, the 2a pro-
tein, with a predicted molecular weight of 31 kDa, was
observed (to the same extent) in lysates prepared from
cells infected with MHV-WT and with MHV-45a but not
from MHV-2aHE- and MHV-min-infected cells.
Finally, the expression of the E gene was analyzed. To
our initial surprise, E protein could only be detected in
control cells infected with the wild-type MHV-A59 strain
from the Utrecht laboratory and not in any of the recom-
binant virus infected cells (Fig. 4D). Careful analysis of
the sequence of the E gene in the Utrecht MHV-A59
TABLE 1
RNA Synthesis by Recombinant MHVsa
Virusb RNA species
RNA length
(nt)c
Molar
ratiod
WT(1) 1a/1b-2a/HE-S-4-5a/E-M-N 31,528 1.00
2a/HE-S-4-5a/E-M-N 9852 0.14
S-4-5a/E-M-N 7677 0.40
4-5a/E-M-N 3664 2.13
5a/E-M-N 3281 1.14
M-N 2641 3.72
N 1944 11.95
WT(2) 1a/1b-2a/HE-S-4-5a/E-M-N 31,528 1.00
2a/HE-S-4-5a/E-M-N 9852 0.15
S-4-5a/E-M-N 7677 0.42
4-5a/E-M-N 3664 2.24
5a/E-M-N 3281 1.24
M-N 2641 3.45
N 1944 12.38
45a 1a/1b-2a/HE-S-E-M-N 30,792 1.00
2a/HE-S-E-M-N 9116 0.29
S-E-M-N 6941 0.59
E-M-N 2935 0.67
M-N 2641 2.03
N 1944 15.74
2aHE 1a/1b-S-4-5a/E-M-N 29,370 1.00
S-4-5a/E-M-N 7677 0.71
4-5a/E-M-N 3664 3.85
5a/E-M-N 3281 1.59
M-N 2641 5.11
N 1944 14.03
min 1a/1b-S-E-M-N 28,634 1.00
S-E-M-N 6941 0.73
E-M-N 2935 0.74
M-N 2641 1.40
N 1944 14.16
a Radioactivity in RNA bands shown in Fig. 3 was quantitated by
scanning with Image Quant Phosphorimager.
b All viruses are recombinant viruses. WT(1) and WT(2) refer to
parallel infections with MHV-WT shown on the left and right side of Fig.
3, respectively.
c RNA length includes a poly(A) tail of 200 nucleotides (nt).
d Molar ratio (g  1) is normalized with respect to moles of genomic
RNA.
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strain revealed that it differs at two nucleotide positions
from the E gene in the transcription vector pMH54 (Kuo
et al., 2000) (A217G and T230C), which is based on the
sequence of the Albany laboratory strain of MHV-A59.
These nucleotide changes result in two amino acid sub-
stitutions (M73V and L77P). The sequence of the E gene
from the Utrecht MHV-A59 is identical to that of MHV-3
(Fischer et al., 1998). Since the anti-E serum was raised
against a fusion protein based on the Utrecht MHV-A59
sequence (Raamsman et al., 2000), we considered this
difference to be the most likely explanation for the lack of
E protein precipitation. Indeed, when we substituted the
two nucleotides in the E gene of pMH54, the resulting
recombinant virus expressed an E protein that could now
be precipitated with our anti-E serum to the same extent
as the E protein produced by the Utrecht MHV-A59 (data
not shown).
Tissue culture growth phenotype
Next we compared the recombinant viruses for their in
vitro growth characteristics. No differences were ob-
served with respect to their cytopathic effects. They all
induced extensive syncytia to the same extent as the
Utrecht wild-type virus, while plaque sizes on LR7 cells
were also not appreciably different. Differences were,
FIG. 4. Analysis of synthesis and release of recombinant MHV proteins. LR7 cells were mock infected or infected with recombinant (WT, 45a,
2aHE, or min) viruses or with the Utrecht laboratory wild-type virus (MHV-A59) as indicated on the top of each gel. Cells were labeled for 3 h with
35S-labeled amino acids starting 5 h postinfection. (A) Both cells (left) and media (right) were prepared and used for immunoprecipitation with the
anti-MHV serum K134, and the precipitates were analyzed by SDS–15% PAGE. (B) For quantitative analysis phosphorimager scanning of the amount
of radioactivity in the M, S, and N proteins in the dried gels of three independent experiments (as shown in A) was performed. The ratios of the
intracellular amount of M and N (M/N) and S and N (S/N) proteins were calculated relative to MHV-WT infected cells and standard deviations are
indicated. The ratio of the amount of M protein present in the culture media and in cells (M outside/inside) was also determined. Cells were also
prepared for immunoprecipitation with the anti-2a serum UP3 (C) and with the anti-E serum K5379 (D). The precipitates were analyzed by SDS–15%
PAGE and SDS–20% PAGE, respectively. The positions of the different proteins are indicated on the right, while the molecular mass marker is indicated
on the left of each gel.
183DELETION OF CORONAVIRUS GROUP-SPECIFIC GENES
however, observed in their one-step growth curves.
Though all viruses displayed similar kinetics, MHV-45a
and MHV-min appeared to reach approximately 10-fold
lower titers than MHV-WT and MHV-2aHE (Fig. 5),
which behaved similar to wild-type MHV-A59 (data not
shown). These observations are consistent with the re-
sults of the immunoprecipitation assays which showed
that, taking the appearance of the M protein as a mea-
sure, MHV-45a and MHV-min were less efficiently as-
sembled and released.
Virulence of recombinant viruses
Having analyzed their in vitro growth characteristics,
the properties of the recombinant viruses were charac-
terized in their natural host, the mouse. Thus, we deter-
mined their virulence. Mice were inoculated intracrani-
ally with 5- or 10-fold serial dilutions of MHV-WT, MHV-
2aHE, MHV-45a, and MHV-min. Infected mice were
observed for clinical signs and lethality. For the recom-
binant wild-type virus a 50% lethal dose (LD50) value of
2.7  104 (mean of two experiments) was calculated
(Hingley et al., 1994; Reed and Muench, 1938). This LD50
value is five to eight times higher than the values that are
usually obtained for MHV-A59 lab strains. Although the
reason for this difference is not clear, it underscores the
importance of taking an isogenic wild-type recombinant
virus along. LD50 values were not able to be calculated
for the three deletion viruses, but must be in excess of
2.5  105, the highest concentration inoculated, as none
of the mice inoculated with this dose died. Figure 6
illustrates the kinetics of mortality of mice infected with
the highest dose inoculated, 2.5  105 plaque forming
units (PFU), of WT and deletion viruses. While all the
animals inoculated with wild-type virus had died by 7
days postinfection, the deletion viruses were highly at-
tenuated, displaying no death and less severe clinical
symptoms. Despite the observation of no mortality, all
mice infected with the 45a and 2aHE viruses showed
clinical signs of hunched posture, disheveled appear-
ance, and waddling gait during the first week postinfec-
tion; these symptoms were less severe and observed in
fewer mice infected with MHV-min. Thus, all deletion
viruses are attenuated relative to wild-type virus; how-
ever, the genetically minimized coronavirus seems atten-
uated more severely than the other deletion viruses.
DISCUSSION
One of the most distinguishing features of the corona-
virus family subgroups is the nature and genomic loca-
tions of their group-specific genes. With the exception of
the HE gene, essentially nothing is yet known about
these genes. We now show for the group 2 coronavirus
MHV, using our newly developed strategy of targeted
recombination, that these group-specific genes are not
essential, since recombinant viruses, from which these
group-specific genes were fully deleted, could be easily
recovered. While deletion of the 2a/HE gene cluster did
not affect growth in vitro, deletion of the 4/5a cluster
resulted in viruses that replicated to a 10-fold lesser
extent. In addition, our work shows that deletion of the
nonessential genes led to significant attenuation of all
the viruses when inoculated into mice and therefore
provides an attractive approach to generate attenuated
live coronavirus vaccines.
Except for the HE protein little is known about the
actual proteins encoded by the group 2 specific corona-
virus genes, and this holds true as well for the group-
specific proteins of the other groups. The HE protein is a
type I glycoprotein, which forms disulfide linked ho-
modimers (Brian et al., 1995 and references therein).
Viruses that express this protein show a second, shorter
fringe of peplomers on their virions. For the HE protein
hemagglutinating and acetyl-esterase activities have
been demonstrated, but the significance of these prop-
FIG. 6. Survival of C57Bl/6 mice infected with MHV recombinants.
Four-week-old mice were inoculated intracranially with various dilu-
tions of recombinant wild-type and deletion viruses (n  5 per virus)
and survival was monitored. The data for mice infected with 2.5  105
PFU are shown. While the animals infected with MHV-WT had all
succumbed by day 7 postinfection, all mice inoculated with the deletion
mutant viruses survived until 21 days postinfection.
FIG. 5. Single-step growth kinetics of the MHV recombinants. LR7
cells were infected with each recombinant MHV at a multiplicity of 8
PFU per cell. Viral infectivity in culture media at different times postin-
fection was determined by a quantal assay on LR7 cells, and 50%
tissue culture infective doses (TCID50) were calculated.
184 DE HAAN ET AL.
erties remains to be established. No enzymatic activities
have been assigned to the other group-specific proteins.
The 31-kDa 2a protein was detected in the cytoplasm of
MHV, bovine coronavirus (BCoV), and human coronavi-
rus (HCoV)-OC43 infected cells (Bredenbeek et al.,
1990a; Cox et al., 1991; Labonte et al., 1995; Zoltick et al.,
1990). The MHV and BCoV 2a proteins share 45% amino
acid identity. The BCoV 2a protein was demonstrated to
be a phosphoprotein (Cox et al., 1991), but this modifica-
tion could not be found for MHV (Bredenbeek et al.,
1990a). While the MHV 2a protein contains a putative
nucleotide binding site (Luytjes et al., 1988), this site is
not conserved in the 2a sequence of BCoV and HCoV-
OC43. Interestingly, the amino-terminal half of the coro-
navirus 2a protein has significant sequence identity with
the carboxyl-terminal part of the torovirus 1a polyprotein
(31–36%) (Snijder et al., 1991), which is presumably in-
volved in viral RNA synthesis. The same 2a protein do-
main is also homologous with the carboxyl-terminal do-
main of the group A rotavirus VP3 protein (20–25%),
which is part of the virion core and has capping activity
(Chen et al., 1999). It cannot be excluded that these
proteins have additional, common functions. Very little is
known about the (putative) gene 4 and 5a products. The
expression product of MHV-JHM (but not of MHV-A59)
gene 4 has been demonstrated in infected cells (Ebner et
al., 1988; Weiss et al., 1993). This protein is predicted to
be an integral membrane protein (Skinner and Siddell,
1985). It has a strikingly high content of threonine resi-
dues outside the hydrophobic region. The putative
ORF5a expression product has not been demonstrated
in infected cells, and it has been proposed that the actual
role of this region is to function as an internal ribosome
entry site for the translation of the E protein. No homol-
ogies have been found for the putative products of ORFs
4 and 5a with other than group 2 coronavirus-specific
sequences.
The coronaviral group-specific genes nor their protein
products are required for replication at the level of the
individual cell. Deletion of the 2a/HE gene cluster was
without appreciable effect on in vitro viral growth, while
viruses lacking the 4/5a cluster reached 10-fold lower
titers. Whether this latter effect was at all due to the
respective proteins not being produced is unclear. The
reduced replication capacity of the 4/5a viruses might
simply be the consequence of the deletion per se. These
viruses exhibited lower transcription efficiencies for the
sgRNAs from which the M and E genes are translated.
The effect thereof on the synthesis of the E protein could
not be analyzed due to the lack of an appropriate anti-
serum. However, the reduced synthesis of the sgRNA
encoding M correlates with the observed slight but sig-
nificant decrease in the M protein expression level. In
view of the essential role of the M and E proteins in viral
assembly (Vennema et al., 1996), this may well explain
the impaired replication capacity of these viruses. A
comparable result was observed for the equine arteritis
virus. This arterivirus has a similar basic genome orga-
nization as MHV and also produces a 3-coterminal
nested set of sgRNAs. A mutation causing a twofold
reduction in the amount of sgRNA3 of this virus resulted
in a corresponding reduction in the amount of GP3 but in
a fourfold reduction of the virus titer (Pasternak et al.,
2000). These results support the notion that corona- and
related viruses (i.e., nidoviruses) have evolved to regu-
late, through the use of sgRNAs, the expression of their
polycistronic genome, thus providing them with a mech-
anism to synthesize their proteins in optimal relative
quantities.
In the past a number of coronaviruses have been
described that carry mutations in or around one or more
of their group-specific genes. While in some cases these
mutations were demonstrated in viral genomes isolated
directly from the animal, very often it is not clear whether
they had been generated during passage of these vi-
ruses in vitro. Obviously, the generally high rate of mu-
tation in RNA viruses and, in addition, the high frequency
of homologous recombination of coronaviruses would be
expected to lead to mutations that we now know not to
hinder the replication capacity in cell culture. For exam-
ple, an efficiently replicating MHV deletion mutant lack-
ing a functional ns2 gene was obtained after extensive in
vitro passaging of an MHV-JHM isolate (Schwarz et al.,
1990). The HE locus is highly heterogeneous among
MHV strains (Luytjes, 1995; Yokomori et al., 1991). While
the gene is intact in strains JHM and S, MHV-A59 does
not express its HE gene as it not only lacks the initiation
codon but also a functional TRS (Luytjes et al., 1988). A
spectrum of 3-truncated HE gene variants was observed
in brains of mice inoculated with a MHV-JHM strain
(Yokomori et al., 1993). Similarly, considerable variation
has also been found in the ORF 4 region of the group 2
coronaviruses. While a single ORF is located in MHV-
JHM (Skinner and Siddell, 1985) and MHV-S (Yokomori
and Lai, 1991), in MHV-A59 gene 4 is disrupted by a
frameshift that results in two ORFs, 4a and 4b, of which
only 4a is expressed (Weiss et al., 1993). The MHV-A59
ORF4b is a shorter homolog of the MHV-JHM ORF4. In
MHV-S the ORF4 is not expressed due to mutations in
the TRS. The BCoV genome also contains two ORFs in
this region, whereas in HCoV-OC43 a deletion has left
only a small portion of the first ORF (Mounir and Talbot,
1993). Less heterogeneity has been observed for ORF5a,
although a deletion in this region has been observed in
MHV-S (Yokomori and Lai, 1991).
Deletion of the coronavirus group-specific genes in a
controlled genetic background generated viruses that
were attenuated in their natural host. The genetically
minimized coronavirus was attenuated more severely
than the other deletion mutant viruses. These observa-
tions suggest that the functional significance of the coro-
navirus group-specific genes relates to their role in vi-
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rus–host interactions. Considering again these viruses’
high frequency of mutation and recombination, these
accessory genes would otherwise not have been main-
tained in the viral genome. However, although deletion of
the MHV 2a/HE gene cluster did not affect replication in
vitro, viruses lacking the 4/5a cluster replicated to a
lesser extent. Therefore, while a functional role for the
2a/HE cluster in vivo seems plausible, the observed
phenotypes of the viruses lacking the 4/5a cluster may
well be caused by their reduced replication per se. In-
deed, a recombinant MHV-JHM in which the gene 4 was
genetically inactivated was not attenuated in a murine
model of encephalitis (Ontiveros et al., 2001). Conse-
quently, as a next step to elucidate the significance of the
MHV group-specific genes in vivo, these genes should
be inactivated by site-specific mutagenesis.
Deletion of the coronavirus group-specific genes pro-
vides an attractive approach to generate attenuated live
coronavirus vaccines. Analogous to MHV, the group-
specific genes of other coronaviruses are anticipated to
be accessory genes, the deletion of which is expected to
result in attenuation without strongly affecting growth in
vitro. In addition, creating genetically minimized corona-
viruses may generate additional space for the stable
insertion of foreign genes. The recent development of
various reverse genetic procedures for coronaviruses
will also enable the study of the other coronavirus group-
specific genes and will finally pave the way for investi-
gations into the pathogenesis of coronaviruses at the
molecular level.
MATERIALS AND METHODS
Cells, viruses, and antibodies
MHV-A59 recombinants WT, 45a, 2aHE, and min
were propagated in mouse LR7 cells (Kuo et al., 2000),
and plaque assays and plaque purifications were carried
out with the same cells. Mouse 17 clone 1 (17Cl1) cells
were used for radiolabeling of intracellular viral RNAs.
Feline FCWF cells (American Type Culture Collection)
were used for infection with the interspecies chimeric
coronavirus virus fMHV (Kuo et al., 2000). The rabbit
polyclonal antiserum K134 to MHV-A59 (Rottier et al.,
1981), the antiserum UP3 to the 2a protein of MHV-A59
(Zoltick et al., 1990), and the antiserum K5379 to the E
protein of MHV-A59 (Raamsman et al., 2000) have been
described previously.
Plasmid constructs
Transcription vectors for the production of synthetic
donor RNA for targeted recombination were derived from
the plasmid pMH54 (Kuo et al., 2000), which specifies a
defective MHV-A59 RNA transcript consisting of the 5
end of the genome (467 nt) fused to codon 28 of the HE
gene and running to the 3 end of the genome (Fig. 1).
Plasmid pMH54 was used to construct a recombinant
wild-type virus MHV-WT. Transcription vector pXH45a
lacks the ORFs 4a, 4b, and almost all of 5a. For the con-
struction of this plasmid a PCR product was obtained from
an MHV-A59-derived cDNA clone, pB59 (Fischer et al.,
1997), by using primer 1089 (5-ACCTGCAGGACTAATCTA-
AACTTTATTCTTTTTAGGGCCACGC-3), which contains a
PstI/Sse8387I restriction sequence and a TRS and which is
complementary to the sequence just upstream of the E
gene, and primer 1092 (5-CCTTAAGGAATTGAACTGC-3),
which is complementary to the 5 end of the M gene. The
PCR product was cloned into pGEM-T Easy (Promega)
according to the manufacturer’s instructions, yielding
pXH0803. The PCR product was subsequently excised with
PstI and EcoRV and cloned into Sse8387-I and EcoRV-
treated pMH54, resulting in pXH45a. Transcription vector
pXH2aHE lacks ORFs 2a and HE and contains approxi-
mately 1200 bp from the 3 end of the replicase gene fused
to the S gene. To construct this plasmid a PCR product was
obtained by splicing overlap extension PCR. One PCR prod-
uct was obtained from another MHV-A59 cDNA clone p96
(Bredenbeek et al., 1990b) using primer 1128 (5-ACGGTC-
CGACTGCGCGCTTGAACACGTTG-3), which contains a
RsrII restriction sequence and is complementary to a re-
gion approximately 1200 bp upstream of the replicase stop
codon, and primer 1130 (5-CATGCAAGCTTTATTTGACATT-
TACTAGGCT-3), which is complementary to the 3 end of
the replicase coding region and the TRS region that is
located upstream of the S gene. The other PCR product
was obtained from pMH54 using primer 1129 (5-GT-
CAAATAAAGCTTGCATGAGGCATAATCTAAAC-3), which is
complementary to primer 1130, and primer 1127 (5-CCAG-
TAAGCAATAATGTGG-3), which is complementary to a re-
gion in the 5 domain of the S gene. The PCR products
were purified, mixed, and used in a PCR with primers
1128 and 1127. The DNA product obtained after the sec-
ond round of PCR was cloned into pGEM-T Easy, yielding
pXH1802. It was excised again with RsrII and AvrII and
cloned into pMH54, which had been treated with the
same enzymes, resulting in pXH2aHE. Transcription
vector pXHmin contains the replicase 3 end fused to the
S gene and the deletion of ORFs 4a, 4b, and 5a. This
vector was constructed by cloning the fragment excised
with PstI and EcoRV from pXH0803 into pXH2aHE,
which had been treated with Sse8387I and EcoRV. The
composition of all PCR-generated segments was con-
firmed by DNA sequencing.
Construction of MHV mutants
Incorporation of mutations into the MHV genome by
targeted RNA recombination was carried out as de-
scribed previously (Hsue et al., 2000). Donor RNAs tran-
scribed from PacI-truncated, pMH54-derived plasmids
were transfected by electroporation into feline FCWF
cells that had been infected 4 h earlier with fMHV (Kuo et
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al., 2000). These cells were then plated onto a monolayer of
mouse LR7 cells. After 24 h of incubation at 37°C, progeny
viruses released into the cell culture media were harvested
and candidate recombinants were selected by two rounds
of plaque purification on LR7 cells. The mutations intro-
duced into the viral genomes were confirmed by sequenc-
ing of RT-PCR products of the relevant regions prepared by
using purified genomic RNA (Fig. 2), which were cloned into
pGEM-T Easy. The primers used for the RT-PCR analysis
were primer 1092, primer 990 (5-CCTGATTTATCTCTC-
GATTTC-3), primer 1261 (5-GCTGCTTACTCCTATCATAC-
3), primer 1127, primer 1173 (5-GACTTAGTCCTCTCCT-
TGA-3), and primer 1260 (5-CTTCAACGGTCTCAGTGC-3)
(Fig. 2).
Radiolabeling of viral RNA
The metabolic labeling of virus-specific RNAs was
carried out essentially as reported previously (Masters et
al., 1994; Hsue and Masters, 1999). Briefly, 17Cl1 cell
monolayers were infected with each MHV recombinant
at a multiplicity of 5 PFU per cell. At 2 h postinfection,
cells were starved for 4 h in Eagle’s MEM containing 5%
dialyzed fetal bovine serum (FBS) and 1/10 of the normal
phosphate concentration. Cells were then labeled for 2 h
with [33P]orthophosphate in phosphate-free Eagle’s MEM
containing 5% dialyzed FBS and 20 g actinomycin D
(Sigma) per milliliter. Total cytoplasmic RNA was purified
using Ultraspec reagent (Biotecx). Samples of RNA were
denatured with formaldehyde and formamide, separated
by electrophoresis through 1% agarose containing form-
aldehyde, and visualized by fluorography.
Metabolic labeling and immunoprecipitation
LR7 cells were grown and infected with each virus at
a multiplicity of 8 PFU per cell. Before being labeled,
cells were starved for 30 min in cysteine- and methi-
onine-free minimal essential medium containing 10 mM
HEPES (pH 7.2) and 5% dialyzed fetal bovine serum. The
medium was then replaced by 600 l of the same me-
dium containing 100 Ci in vitro cell-labeling mix (Amer-
sham). Cells were labeled from 5 to 8 h postinfection. At
the end of the labeling period, culture media were col-
lected, cleared by low-speed centrifugation, and pre-
pared for immunoprecipitation by the addition of 1/4 vol
of 5 concentrated lysis buffer (de Haan et al., 1998).
Proteins were immunoprecipitated from cell lysates as
described before (de Haan et al., 1998). Per immunopre-
cipitation 2.5 l of anti-MHV, 3 l of anti-E serum, and 3
l of anti-2a serum were used. Immune complexes were
adsorbed to Pansorbin cells (Calbiochem) for 30 min at
4°C and were subsequently collected by centrifugation.
Pellets were washed four times by resuspension and
centrifugation using wash buffers as described before
(de Haan et al., 1998). The final pellets were suspended
in electrophoresis sample buffer. The immunoprecipi-
tates were heated for 2 min at 95°C and analyzed by
SDS–PAGE in 15% polyacrylamide gels.
One-step growth curve
LR7 cell monolayers were grown in 35-mm dishes in
DMEM supplemented with 10% FBS. Confluent monolay-
ers were infected in parallel with each virus (8 PFU/cell)
and incubated for 1 h at 37°C. After absorption, the cells
were washed with PBS three times and then fed with 2
ml of DMEM–10% FBS. Viral infectivity in culture media at
different times postinfection was determined by a quan-
tal assay on LR7 cells, and 50% tissue culture infective
doses (TCID50) were calculated.
Animals
C57Bl/6 (B6) mice were purchased from the National
Cancer Institute (Frederick, MD). Four-week-old, MHV-
free male mice were used in all experiments. Mice were
anesthetized with isoflurane (IsoFlo; Abbott Laboratories,
North Chicago, IL). The amount of virus designated in
each experiment was diluted in PBS containing 0.75%
bovine serum albumin, and a total volume of 20 l was
injected into the left cerebral hemisphere. Mock-infected
controls were inoculated similarly.
Virulence assays
LD50 assays were carried out as described previously
(Hingley et al., 1994). Mice were inoculated intracranially
with 5- or 10-fold serial dilutions of recombinant viruses.
A total of five animals per dilution per virus were ana-
lyzed. Mice were examined for signs of disease or death
on a daily basis up to 21 days postinfection. LD50 values
were calculated by the Reed–Muench method (Reed and
Muench, 1938).
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